US FDA accredits GS1, HIBCC for issuing device identifiers as UDI rule architect departs
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has accredited two global standards organizations, GS1 and the Health Industry Business Communications Council (HIBCC), for issuing unique device identifiers to support the implementation of the agency's new UDI regulations1,2. Separately, Jay Crowley, who was instrumental in authoring the FDA's UDI rule, is leaving the agency to join private consultancy firm USDM Life Sciences3.
You may also be interested in...
New Draft Guidance From FDA Paints Way Forward For Unique Device Identifiers
US FDA lays out for manufacturers how they should cobble together Unique Device Identifiers in a 10-page July 25 draft guidance. The document is intended to be a handy manual for firms as they work to meet UDI requirements and deadlines set by the agency.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.